Cover Image

Clinical utility of pharmacogenomics in the management of hepatitis C

Julieta Trinks,1,2 María Laura Hulaniuk,1 María Ana Redal,1,3 Diego Flichman2,4 1Instituto de Ciencias Básicas y Medicina Experimental, Hospital Italiano de Buenos Aires, 2National Scientific and Technical Research Council, 3Instituto Universitario del Hospital Itali...

Full description

Saved in:

Bibliographic Details
Main Authors:	Trinks J (Author), Hulaniuk ML (Author), Redal MA (Author), Flichman D (Author)
Format:	Book
Published:	Dove Medical Press, 2014-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals
by: Trinks J, et al.
Published: (2017)

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments
by: Marta Hernandez, et al.
Published: (2024)

Clinical implementation of RNA signatures for pharmacogenomic decision-making
by: Tang W, et al.
Published: (2011)

Utilizing Pharmacogenomics Results to Determine Opioid Appropriateness and Improve Pain Management in a Patient with Osteoarthritis
by: Pizzolato K, et al.
Published: (2022)

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
by: Eric Rytkin, et al.
Published: (2023)

Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients
by: Carla Miranda, et al.
Published: (2021)

Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019)

Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
by: Yang CHT, et al.
Published: (2018)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Letter]
by: Roman YM
Published: (2021)

Pharmacogenomics in clinical trials: an overview
by: Rita Nogueiras-Álvarez
Published: (2023)

Impact of Pharmacogenomics in Clinical Practice
by: Nicola Principi, et al.
Published: (2023)

Editorial: Pharmacogenetics and Pharmacogenomics in Latin America: Ethnic Variability, New Insights in Advances and Perspectives: A RELIVAF-CYTED Initiative
by: Patricia Esperón, et al.
Published: (2022)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: George P. Patrinos, et al.
Published: (2023)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
by: Takahashi PY, et al.
Published: (2021)

Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II
by: Andrés López-Cortés, et al.
Published: (2023)

Pharmacogenomics Statins: Biomarkers for Clinical Prediction
by: Herni Suprapti
Published: (2018)

Current clinical evidence on pioglitazone pharmacogenomics
by: Marina eKawaguchi-Suzuki, et al.
Published: (2013)

Clinical Application and Educational Training for Pharmacogenomics
by: Jason W. Guy, et al.
Published: (2020)

Pharmacogenomics: introduction and use in clinical practice
by: Saunders Hollie, et al.
Published: (2020)

Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C
by: P. Marrero-Álvarez, et al.
Published: (2014)

Impact of CYP2C9‐Interacting Drugs on Warfarin Pharmacogenomics
by: Saaket Agrawal, et al.
Published: (2020)

No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study
by: Takahashi PY, et al.
Published: (2021)

Pharmacogenomics From Basic Research to Clinical Implementation
Published: (2022)

Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system
by: Joel Van Heukelom, et al.
Published: (2023)

Landmarks of pharmacogenomics and some considerations for clinical practice
by: David Nana Ampong
Published: (2019)

The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics
by: Abdullah Al Maruf, et al.
Published: (2023)

Pharmacogenomics of Cardiovascular Pharmacology: Pharmacogenomic Network of Cardiovascular Disease Models
by: Toshio Tanaka, et al.
Published: (2008)

Pharmacogenomics in the newborn
by: Mirta Corsello, et al.
Published: (2013)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
by: Coons JC, et al.
Published: (2023)

Transitioning pharmacogenomics into the clinical setting: training future pharmacists
by: Amber Frick, et al.
Published: (2016)

Integrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow
by: Efstathia Giannopoulou, et al.
Published: (2019)

Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice
by: Mariamena Arbitrio, et al.
Published: (2021)

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice
by: Alireza Tafazoli, et al.
Published: (2021)

Assessing pharmacogenomic literacy in China through validation of the Chinese version of the Minnesota Assessment of Pharmacogenomic Literacy
by: Lusi Zhang, et al.
Published: (2023)

Pharmacogenomics of hyaluronic acid
by: Elena E. Vaiman, et al.
Published: (2021)

Pharmacogenomics and Personalized Medicine
Published: (2020)

Pharmacogenomics: what is next?
by: Julia edi Iulio, et al.
Published: (2012)

Editorial: NSAIDs Pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2021)

Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders
by: Bose-Brill S, et al.
Published: (2017)

PAnno: A pharmacogenomics annotation tool for clinical genomic testing
by: Yaqing Liu, et al.
Published: (2023)